Knee osteoarthritis Musculoskeletal Diseases Gonarthrosis [arthrosis of knee]
Conditions
Interventions
The treatment group will receive regenerative photonic therapy (RPT) plus exercises while the control group will receive placebo (dummy) RPT and exercises.
Sponsors
International Medical Instruments Inc. (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 50-85 years old 2. Patients suffering from chronic (more than 6 months duration) knee osteoarthritis (OA) pain 3. Able to provide informed consent in a written form
Exclusion criteria
Exclusion criteria: 1. Surgical joint replacement 2. Radiological grade 1 and 4 osteoarthritis 3. Oral opioid or steroid medications 4. Recent ( 11, or glucose in urine) 17. Neurological manifestations (numbness, paraesthesia, loss of sensitivity anywhere in the body) 18. Known autoimmune diseases (e.g., lupus, rheumatoid arthritis)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Western Ontario and McMaster Universities Arthritis Index (WOMAC) subscale difficulties performing daily activities (DPDA) 2. Walking pain by Visual Analog Scale (VAS, 0 = no pain, 10 = worst possible pain) Primary outcomes will be measured upon completion of 6 weeks treatment, at one month and six months follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. WOMAC Total 2. WOMAC Pain subscale 3. The highest weekly pain by Visual Analog Scale (VAS, 0 = no pain, 10 = worst possible pain) 4. Pain medication intake (amount of pain pills per day) Secondary outcomes will be measured upon completion of 6 weeks treatment, at one month and six months follow-up. | — |
Countries
Canada
Outcome results
None listed